** = Publikationen gelistet in SCI/SSCI/Pubmed
** Pieber, TR; Svehlikova, E; Fluhr, G; Höller, V; Gatschelhofer, C; Lackner, B; Magnes, C; Ratzer, M; Jezek, J; Howell, SJ; Gerring, D; Zakrzewski, L; Pillai, V; Murray, S
Pharmacokinetic and pharmacodynamic properties of highly concentrated insulin aspart AT278 U500 in overweight and obese people with type 2 diabetes
DIABETOLOGIA. 2024; 67: S534-S534.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Poster]
Web of Science
** Svehlikova, E; Regittnig, W; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Eberl, A; Pieber, TR
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
DIABETOLOGIA. 2024; 67: S346-S347.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Poster]
Web of Science
** Svehlikova, E; Regittnig, W; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Eberl, A; Pieber, TR
Dapagliflozin reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
DIABETOLOGIA. 2024; 67: S128-S129.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Pieber, TR; Asong, M; Fluhr, G; Holler, V; Kristensen, NR; Larsen, JH; Ribel-Madsen, R; Svehlikova, E; Vinther, S; Voortman, M; Haahr, H
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes
DIABETES OBES METAB. 2023;
Doi: 10.1111/dom.15266
Web of Science
PubMed
FullText
FullText_MUG
** Svehlikova, E; Holler, V; Gumilar, J; Fluhr, G; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, DJ; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, FJ; Pieber, TR
Phase I study investigating PK and -PD of highly-concentrated insulin aspart AT278 U500
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-262.
[Oral Communication]
Web of Science